Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial
口服20-羟基蜕皮激素（BIO101，一种MAS受体激活剂）治疗重症COVID-19成人患者的疗效（COVA）：一项随机、安慰剂对照的II/III期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2023.102383
Lobo, Suzana Margareth; Plantefève, Gaétan; Nair, Girish; Joaquim Cavalcante, Adilson; Franzin de Moraes, Nara; Nunes, Estevao; Barnum, Otis; Berdun Stadnik, Claudio Marcel; Lima, Maria Patelli; Lins, Muriel; Hajjar, Ludhmila Abrahao; Lipinski, Christopher; Islam, Shaheen; Ramos, Fabiano; Simon, Tiago; Martinot, Jean-Benoît; Guimard, Thomas; Desclaux, Arnaud; Lioger, Bertrand; Neuenschwander, Fernando Carvalho; DeSouza Paolino, Bruno; Amin, Alpesh; Acosta, Samuel Amil; Dilling, Daniel Forde; Cartagena, Edgardo; Snyder, Brian; Devaud, Edouard; Barreto Berselli Marinho, Ana Karolina; Tanni, Suzana; Milhomem Beato, Patricia Medeiros; De Wit, Stephan; Selvan, Vani; Gray, Jeffrey; Fernandez, Ricardo; Pourcher, Valérie; Maddox, Lee; Kay, Richard; Azbekyan, Anait; Chabane, Mounia; Tourette, Cendrine; Esmeraldino, Luis Everton; Dilda, Pierre J; Lafont, René; Mariani, Jean; Camelo, Serge; Rabut, Sandrine; Agus, Samuel; Veillet, Stanislas; Dioh, Waly; van Maanen, Rob; Morelot-Panzini, Capucine
